## KMX: CarMax, Inc. - XLY: Consumer Cyclical

### Executive Summary

No thesis match: MRS_10 -0.4% below STRENGTH zone (3.0-6.0%). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($36.49)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 0, Bearish: 10)

**1. |CarMax 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Remind Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuits Against CarMax, Inc. - KMX**
- Source: The AI Journal | 20251231T020829 | Bearish | Relevance: 100%
- |Kahn Swick & Foti, LLC (KSF) is reminding investors with losses over $100,000 in CarMax, Inc. (NYSE: KMX) to file as lead plaintiffs in a securities class action lawsuit by January 2, 2026. The lawsuits allege CarMax and its executives failed to disclose material information, leading to a significant stock price drop after disappointing Q2 Fiscal Year 2026 financial results were announced on September 25, 2025. Investors who purchased KMX securities between June 20, 2025, and November 5, 2025, are encouraged to contact KSF to discuss their legal rights.

**2. DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of CarMax**
- Source: GlobeNewswire | 20251230T160759 | Bearish | Relevance: 100%
- Faruqi & Faruqi, LLP is investigating potential claims against CarMax, Inc. (NYSE: KMX) and reminds investors of the January 2, 2026 deadline to seek the role of lead plaintiff in a federal securities class action. The lawsuit alleges CarMax overstated growth prospects and failed to disclose worsening loan performance, leading to a significant stock price drop. Investors who suffered losses between June 20, 2025, and September 24, 2025, are encouraged to contact the firm.

**3. Portnoy Law Firm Announces Class Action on Behalf of CarMax, Inc. Investors**
- Source: GlobeNewswire | 20251230T100200 | Bearish | Relevance: 100%
- The Portnoy Law Firm has announced a class action lawsuit on behalf of CarMax, Inc. (NYSE: KMX) investors who purchased securities between March 5, 2024, and October 8, 2025. This action follows CarMax's disappointing Q2 2026 financial results, which included significant sales declines attributed partly to a "pull forward" in demand due to tariff announcements. Investors have until January 2, 2026, to file a lead plaintiff motion.

**4. CARMAX URGENT ALERT: Bragar Eagel & Squire, P.C. Reminds CarMax Investors of the January 2nd Deadline and Urges Investors to Contact the Firm**
- Source: GlobeNewswire | 20251229T231731 | Bearish | Relevance: 100%
- Bragar Eagel & Squire, P.C., a stockholder rights law firm, has filed a class action lawsuit against CarMax, Inc. (NYSE: KMX) on behalf of investors who purchased securities between June 20, 2025, and September 24, 2025. The lawsuit alleges CarMax made false and misleading statements about its growth prospects and failed to disclose that earlier growth was a temporary benefit from tariff speculation, leading to investor losses when true financial details emerged. Investors have until January 2, 2026, to apply to be appointed as lead plaintiff.

**5. SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A**
- Source: GlobeNewswire | 20251229T140830 | Bearish | Relevance: 100%
- Bernstein Liebhard LLP has filed a securities fraud class action lawsuit against CarMax, Inc. (NYSE: KMX) on behalf of investors who purchased shares between June 20, 2025, and November 5, 2025. The lawsuit alleges that CarMax made misrepresentations regarding its growth prospects. Investors who lost money are encouraged to visit the firm's website or contact Peter Allocco to discuss their legal options and potentially serve as a lead plaintiff by January 2, 2026.

### Analyst Activity

**Target Signal:** BEARISH (Raises: 4, Lowers: 5)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-19 | Barclays | $24 | $28 | -14% |
| 2025-12-19 | Truist Securiti | $37 | $35 | +6% |
| 2025-12-19 | B of A Securiti | $31 | $27 | +15% |
| 2025-12-19 | JP Morgan | $28 | $30 | -7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-19 | Barclays | main | Underweight |
| 2025-12-19 | Truist Securiti | main | Hold |
| 2025-12-19 | B of A Securiti | main | Underperform |
| 2025-12-19 | JP Morgan | main | Underweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 2 ($0.59M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 43.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 5 |

**Top Holders:**
- Vanguard Group Inc: 11.9% (-3.8%)
- Blackrock Inc.: 8.1% (+5.9%)
- State Street Corpora: 3.9% (-2.2%)
- Janus Henderson Grou: 3.4% (+1.0%)
- Diamond Hill Capital: 3.4% (-30.6%)

### Key Risks

1. Elevated short interest (10.7%): bears positioning against stock.
2. Long-term trend broken: trading 30.5% below SMA200.
3. Falling knife pattern: rapid decline without stabilization, catch risk elevated.

### Catalysts

- Analyst target momentum: 4 raises (avg +9%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 0.69 indicates undervaluation relative to growth. Balance sheet: $1.1B free cash flow. Analyst sentiment negative (5 target cuts vs 4 raises). Insider buying signal ($0.6M), management confidence. Institutional flow bullish (5 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $5.8B |
| Beta | 1.29 |
| 52W Range | $30.26 - $89.47 |
| Short Interest | 10.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 0.69 |
| Forward P/E | 15.2 |
| Current P/E | 14.8 |
| YoY Growth | -3.2% |
| EPS Direction | FALLING |

### Technicals

MRS_10 strengthening from -5.3% to -0.4% (+4.9% in 5 days), confirming momentum buildup. Below STRENGTH zone by 3.4pp (needs >3.0% for momentum thesis). MRS_5 turning positive (1.1%) - potential reversal signal. Below SMA200 (0.69x), long-term trend not supportive. RSI neutral at 51. OFD pattern: +SUL (Resistance test).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -0.43% (CS: 48) | Neutral |
| RSI_14 | 50.8 | Neutral |
| MACD Histogram | -0.05 | Bearish |
| vs SMA20 | 0.993x | Below |
| vs SMA50 | 1.013x | Above |
| vs SMA200 | 0.695x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $39.31
- **Stop Loss:** $36.49 (7.2% risk)
- **Target:** $42.13 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 390
- **Position Value:** $15,330.90
- **Portfolio %:** 15.33%
- **Risk Dollars:** $1,100.00
- **Risk Per Trade:** 1.10%
- **Modifiers:** L1 110% | L2 100% | Combined 1.10x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.10x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk signals and moderate market participation. VIX at 14.33 indicates calm conditions, while positive yield curve (+59bps) and stable economic data support continued expansion. Year-end positioning and Fed uncertainty create near-term caution, but no systemic risks evident.*

### Earnings

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.32 | $0.43 | +36.1% |
| 2025Q3 | $1.04 | $0.64 | -38.6% |
| 2025Q2 | $1.17 | $1.38 | +18.3% |
| 2025Q1 | $0.66 | $0.58 | -12.3% |

---
*RULE-based L3 | 2026-01-06 16:38 | MRS_10*